Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study

American Heart Journal

Volumn 157, Issue 3, 2009, Pages

  Bi, Yufang ^a   Gao, Runlin ^b   Patel, Anushka ^a   Su, Steve ^a   Gao, Wei ^c   Hu, Dayi ^d   Huang, Dejia ^e   Kong, Lingzhi ^f   Qi, Wenhang ^g   Wu, Yangfeng ^h   Yang, Yuejin ^b   Turnbull, Fiona ^a  

^a GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

^b FUWAI HOSPITAL   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^e SICHUAN UNIVERSITY   (China)

^f BEIJING HOSPITAL   (China)

^g SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^h George Institute for International Health   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CHINA; CHINESE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG USE; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; FEMALE; HEALTH INSURANCE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UNSTABLE ANGINA PECTORIS;

EID: 60649116933     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.09.026     Document Type: Article

References (19)

1. Beaglehole R. Global cardiovascular disease prevention: time to get serious. Lancet 358 (2001) 661-663
2. Wu Z.S., Yao C.H., Zhao D., et al. Sino-MONICA Project, A collaborative study on trends and determinants in cardiovascular diseases in China, Part I: Morbidity and mortality monitoring. Circulation 103 (2001) 462-468
3. Zhao D., Wu Z.S., Wang W., et al. Sino-MONICA: the trend of incidence rate of acute coronary events from 1985 to 1997 in Beijing area. Chin J Cardiol 27 (2000) 14-17
4. Gislason G.H., Rasmussen J.N., Abildstrøm S.Z., et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 27 (2006) 1153-1158
5. Sud A., Kline-Rogers E.M., Eagle K.A., et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother 39 (2005) 1792-1797
6. Gao R., Patel A., Gao W., et al. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart 94 (2008) 554-560 (Electronic Publication 2007 Oct 11)
7. Fox K. Registries and surveys in acute coronary syndrome. Eur Heart J 27 (2006) 2260-2262
8. Steg P., Goldberg R., Gore J., et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90 (2002) 358-363
9. Ohman E.M., Granger C.B., Harrington R.A., et al. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA 284 (2000) 876-878
10. R Development Core Team. R: A language and environment for statistical computing (2007), R Foundation for Statistical Computing, Vienna, Austria. 3-900051-07-0. http://www.R-project.org Last accessed April 2007
11. China Statistical Yearbook 2006. Available at: www.stats.gov.cn. Last accessed April 2007.
12. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA 247 (1982) 1707-1714
13. Wald N.J., and Law M.R. A strategy to reduce cardiovascular disease by more than 80%. BMJ 326 (2003) 1419-1424
14. CRUSADE Executive Committee. 2005 CRUSADE 4th quarter results. Available at:. http://www.crusadeqi.com Last accessed April 2007
15. Budaj A., Brieger D., Steg P.G., et al. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 146 (2003) 999-1006
16. Van de Werf F. Dual antiplatelet therapy in high-risk patients. Eur Heart J Suppl (2007) D3-D9
17. Mandelzweig L., Battler A., Boyko V., et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 27 (2006) 2285-2293
18. Mojtabai R., and Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Affairs 22 (2003) 220-229
19. Xu L., Wang Y., Collins C.D., et al. Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003. BMC Health Serv Res 7 (2007) 37